Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026

What the insiders did Net selling

Nothing of that kind in this period.

What was left out

Form 4 filings counted 34
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 868,776
History held since 8 Apr 2020